Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Ecopipam

Ecopipam (SCH 39166) is a potent, selective and orally active antagonist of dopamine D1/D5 receptor, with Kis of 1.2 nM and 2.0 nM, respectively. Ecopipam shows more than 40-flod selectivity over D2, D4, 5-HT, and α2a receptor (Ki=0.98, 5.52, 0.08, and 0.73 μM, respectively) . Ecopipam can be used for the research of schizophrenia and obesity[1][3].

Product Specifications

CAS Number

112108-01-7

Product Name Alternative

SCH 39166

UNSPSC

12352005

Target

5-HT Receptor; Adrenergic Receptor; Dopamine Receptor

Type

Reference compound

Related Pathways

GPCR/G Protein; Neuronal Signaling

Applications

Metabolism-protein/nucleotide metabolism

Field of Research

Metabolic Disease; Neurological Disease

Assay Protocol

https://www.medchemexpress.com/ecopipam.html

Purity

99.77

Solubility

DMSO : 25 mg/mL (ultrasonic)

Smiles

OC1=C(Cl)C=C2C([C@]3([H])[C@@](CCC4=C3C=CC=C4)([H])N(C)CC2)=C1

Molecular Formula

C19H20ClNO

Molecular Weight

313.82

References & Citations

[1]Wu WL, et, al. Dopamine D1/D5 receptor antagonists with improved pharmacokinetics: design, synthesis, and biological evaluation of phenol bioisosteric analogues of benzazepine D1/D5 antagonists. J Med Chem. 2005 Feb 10;48 (3) :680-93. |[2]Sharopov S, et al. Dopaminergic modulation of low-Mg²⁺-induced epileptiform activity in the intact hippocampus of the newborn mouse in vitro. J Neurosci Res. 2012 Oct;90 (10) :2020-33. |[3]Satanove DJ, et al. Nicotine-induced enhancement of a sensory reinforcer in adult rats: antagonist pretreatment effects. Psychopharmacology (Berl) . 2021 Feb;238 (2) :475-486. |[4]R E Chipkin, et al. Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity. J Pharmacol Exp Ther. 1988 Dec;247 (3) :1093-102. |[5]E Acquas, et al. Local application of SCH 39166 reversibly and dose-dependently decreases acetylcholine release in the rat striatum. Eur J Pharmacol. 1999 Nov 3;383 (3) :275-9.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, sealed storage, away from moisture)

Scientific Category

Reference compound1

Clinical Information

Phase 3

Isoform

D1 Receptor; D2 Receptor; D4 Receptor; D5 Receptor; MUC4; α adrenergic receptor

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Human campylobacter jejuni (CJ) antibody (IgM) ELISA Kit
MBS167960-01 96 Well

Human campylobacter jejuni (CJ) antibody (IgM) ELISA Kit

Sign In for Pricing
View Details
Human campylobacter jejuni (CJ) antibody (IgM) ELISA Kit
MBS167960-02 5x 96 Well

Human campylobacter jejuni (CJ) antibody (IgM) ELISA Kit

Sign In for Pricing
View Details
Human campylobacter jejuni (CJ) antibody (IgM) ELISA Kit
MBS167960-03 10x 96 Well

Human campylobacter jejuni (CJ) antibody (IgM) ELISA Kit

Sign In for Pricing
View Details
ZC3H8 Blocking Peptide
CBP2816-01 1 mg

ZC3H8 Blocking Peptide

Sign In for Pricing
View Details
ZC3H8 Blocking Peptide
CBP2816-02 5 mg

ZC3H8 Blocking Peptide

Sign In for Pricing
View Details
Recombinant Rhizobium loti UPF0187 protein mll4386 (mll4386)
MBS7039549-01 0.02 mg

Recombinant Rhizobium loti UPF0187 protein mll4386 (mll4386)

Sign In for Pricing
View Details